[
  {
    "date": "2023-12-30",
    "symbol": "COYA",
    "period": "FY",
    "netincomeloss": -7987836,
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "Coya Therapeutics, Inc.",
    "entitycentralindexkey": 1835022,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "icfrauditorattestationflag": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "entitywellknownseasonedissuer": "No",
    "entityshellcompany": "false",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "tradingsymbol": "COYA",
    "securityexchangename": "NASDAQ",
    "entityfilenumber": "001-41583",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "85-4017781",
    "entityaddressaddressline1": "5850 San Felipe St., Suite 500",
    "entityaddresscityortown": "Houston",
    "entityaddressstateorprovince": "TX",
    "entityaddresspostalzipcode": 77057,
    "cityareacode": 800,
    "localphonenumber": "587-8170",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "auditorfirmid": 410,
    "auditorname": "Weaver and Tidwell, L.L.P.",
    "auditorlocation": "Austin, Texas",
    "cashandcashequivalentsatcarryingvalue": 32626768,
    "collaborationreceivablecurrent": 7500000,
    "prepaidexpenseandotherassetscurrent": 1069557,
    "assetscurrent": 41196325,
    "propertyplantandequipmentnet": 65949,
    "assets": 41262274,
    "accountspayablecurrent": 1155656,
    "accruedliabilitiescurrent": 2973215,
    "deferredrevenuecurrent": 923109,
    "liabilitiescurrent": 5051980,
    "deferredcollaborationrevenue": 574685,
    "liabilities": 5626665,
    "commonstockvalue": 1441,
    "additionalpaidincapital": 61501801,
    "stockholdersequitynotesubscriptionsreceivable": 11250,
    "retainedearningsaccumulateddeficit": -25856383,
    "stockholdersequity": 35635609,
    "liabilitiesandstockholdersequity": 41262274,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 200000000,
    "commonstocksharesissued": 14405325,
    "commonstocksharesoutstanding": 14405325,
    "revenues": 6002206,
    "researchanddevelopmentexpenseexcludingacquiredinprocesscost": 5501527,
    "inprocessresearchanddevelopment": 543186,
    "generalandadministrativeexpense": 7833481,
    "depreciation": 27361,
    "operatingexpenses": 13905555,
    "operatingincomeloss": -7903349,
    "othernonoperatingincomeexpense": 639365,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -7263984,
    "incometaxexpensebenefit": 723852,
    "earningspersharebasic": -0.79,
    "earningspersharediluted": -0.79,
    "weightedaveragenumberofsharesoutstandingbasic": 10163850,
    "weightedaveragenumberofdilutedsharesoutstanding": 10163850,
    "sharesoutstanding": 14405325,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": -8793637,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": -7500713,
    "stockissuedduringperiodvaluenewissues": 329,
    "stockissuedduringperiodsharesnewissues": 3287804,
    "stockissuedduringperiodvaluestockoptionsexercised": 8,
    "stockissuedduringperiodsharesstockoptionsexercised": 85528,
    "exercisevalueofwarrants": 11250,
    "exerciseofwarrants": 1500,
    "stockbasedcompensationexpenseandvestingofrestrictedstockunits": 2,
    "stockbasedcompensationexpenseandvestingofrestrictedstockunitsshares": 16500,
    "paymentsofstockissuancecosts": 2300000,
    "stockissuancecostsincurred": 2500000,
    "profitloss": -7987836,
    "sharebasedcompensation": 872248,
    "increasedecreaseincollaborationreceivable": 7500000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -181707,
    "increasedecreaseinaccountspayable": 298816,
    "increasedecreaseinaccruedliabilities": 877913,
    "increasedecreaseindeferredrevenue": 1497794,
    "netcashprovidedbyusedinoperatingactivities": -11188811,
    "paymentstoacquireinprocessresearchanddevelopment": 543186,
    "netcashprovidedbyusedininvestingactivities": -543186,
    "proceedfromsaleofcommonstockfromprivateplacementnetofofferingcost": 24084805,
    "proceedsfromissuanceinitialpublicoffering": 14250311,
    "proceedsfromstockoptionsexercised": 89947,
    "netcashprovidedbyusedinfinancingactivities": 38425063,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": 26693066,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 32626768,
    "conversionofconvertiblepreferredstockuponinitialpublicoffering": 8793637,
    "conversionofconvertiblepromissorynotesuponinitialpublicoffering": 12965480,
    "subscriptionreceivablerelatedtowarrantexercise": 11250,
    "privateplacementfinancingcostinaccruedexpenses": 86940,
    "privateplacementfinancingcostinaccountspayable": 44978,
    "numberofoperatingsegments": 1,
    "finitelivedintangibleassetscostincurredtoreneworextend": 100000,
    "propertyplantandequipmentusefullife": "P5Y",
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "true",
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "2023-01-01",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 2492241,
    "cashandcashequivalentsfairvaluedisclosure": 32626768,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilityconversionofdebt": 12965480,
    "prepaidresearchanddevelopment": 125000,
    "prepaidinsurance": 858541,
    "otherprepaidexpensecurrent": 86016,
    "propertyplantandequipmentgross": 136804,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 70855,
    "accruedresearchanddevelopment": 686883,
    "accruedemployeebenefitscurrent": 1081262,
    "accruedprofessionalfeescurrent": 481218,
    "accruedincometaxescurrent": 723852,
    "researchanddevelopmentexpense": 300000,
    "classofwarrantorrightoutstanding": 1523500,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 7.5,
    "classofwarrantorrightexercised": 1500,
    "wrrantsorrightexpirationdate": "2024-12",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 1244857,
    "commonstockcapitalsharesreservedforfutureissuance": 24746,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 1800000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y1M6D",
    "allocatedsharebasedcompensationexpense": 545149,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnetsharesettled": 2784,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 1134145,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 760042,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 18939,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 442679,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 1134145,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 3.24,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 3.9,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 1.17,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 3.48,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 2.53,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 3.24,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P8Y2M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P8Y8M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 345293,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 4724761,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 2158479,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 4724761,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y9M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.9382,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 16500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantedandvestedinperiod": 16500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 4.61,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantedandvesteddatefairvalue": 4.61,
    "currentfederaltaxexpensebenefit": 718582,
    "federalincometaxexpensebenefitcontinuingoperations": 718582,
    "currentstateandlocaltaxexpensebenefit": 5270,
    "stateandlocalincometaxexpensebenefitcontinuingoperations": 5270,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationpermanentdifferences": 0.002,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.001,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.029,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": 0.002,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.342,
    "effectiveincometaxratereconciliationotheradjustments": 0.001,
    "effectiveincometaxratecontinuingoperations": 0.101,
    "deferredtaxassetsstartupcosts": 2945099,
    "deferredtaxassetssection174capitalization": 1860806,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 144105,
    "deferredtaxassetsoperatinglosscarryforwards": 439349,
    "deferredtaxassetstaxdeferredexpenseaccruedexpensesandother": 45133,
    "deferredtaxassetscapitalizedlicensefees": 47526,
    "deferredtaxassetstaxcreditcarryforwards": 30035,
    "deferredtaxassetsdeferredincome": 121388,
    "deferredtaxliabilitiespropertyplantandequipment": 8325,
    "deferredtaxassetsvaluationallowance": 5625116,
    "operatinglosscarryforwards": 2100000,
    "operatinglosscarryforwardpercentageoffederaltaxableincome": 0.8,
    "taxcreditcarryforwardexcesspercentageofchangeinownershipinterest": 0.5,
    "upfrontnonrefundablepaymentreceivable": 7500000,
    "revenueremainingperformanceobligation": 1500000,
    "contractwithcustomerliabilityrevenuerecognized": 6000000
  },
  {
    "date": "2022-12-30",
    "symbol": "COYA",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "Coya Therapeutics, Inc.",
    "entitycentralindexkey": 1835022,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated filer",
    "icfrauditorattestationflag": "false",
    "entitywellknownseasonedissuer": "No",
    "entityshellcompany": "true",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "tradingsymbol": "COYA",
    "securityexchangename": "The Nasdaq Stock Market LLC",
    "entityfilenumber": "001-41583",
    "entityincorporationstatecountrycode": "Delaware",
    "entitytaxidentificationnumber": "85-4017781",
    "entityaddressaddressline1": "5850 San Felipe St., Suite 500",
    "entityaddresscityortown": "Houston",
    "entityaddressstateorprovince": "TX",
    "entityaddresspostalzipcode": 77057,
    "cityareacode": 800,
    "localphonenumber": "587-8170",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "auditorfirmid": 410,
    "auditorname": "Weaver and Tidwell, L.L.P.",
    "auditorlocation": "Austin, Texas",
    "cashandcashequivalentsatcarryingvalue": "null",
    "prepaidexpenseandotherassetscurrent": "null",
    "assetscurrent": "null",
    "propertyplantandequipmentnet": 93310,
    "deferredfinancecostsnoncurrentnet": "null",
    "assets": "null",
    "accountspayablecurrent": "null",
    "accruedliabilitiescurrent": "null",
    "liabilitiescurrent": "null",
    "convertiblelongtermnotespayable": "null",
    "liabilities": "null",
    "preferredstockvalue": "null",
    "commonstockvalue": 259,
    "additionalpaidincapital": 681106,
    "retainedearningsaccumulateddeficit": "-null",
    "stockholdersequity": "-null",
    "liabilitiesandstockholdersequity": "null",
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": "null",
    "preferredstocksharesissued": "null",
    "preferredstocksharesoutstanding": "null",
    "preferredstockliquidationpreferencevalue": "null",
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "researchanddevelopmentexpenseexcludingacquiredinprocesscost": "null",
    "researchanddevelopmentinprocess": 525000,
    "generalandadministrativeexpense": "null",
    "depreciation": 27361,
    "operatingexpenses": "null",
    "operatingincomeloss": "-null",
    "changeinfairvalueofconvertiblepromissorynotes": "null",
    "othernonoperatingincomeexpense": 63673,
    "netincomeloss": "-null",
    "earningspersharebasic": -4.73,
    "earningspersharediluted": -4.73,
    "weightedaveragenumberofsharesoutstandingbasic": "null",
    "weightedaveragenumberofdilutedsharesoutstanding": "null",
    "sharesoutstanding": "null",
    "stockissuedduringperiodvaluestockoptionsexercised": 158,
    "stockissuedduringperiodsharesstockoptionsexercised": 146,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 207346,
    "profitloss": "-null",
    "sharebasedcompensation": 207346,
    "amortizationoffinancingcosts": 997367,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 920002,
    "increasedecreaseinaccountspayable": 845284,
    "increasedecreaseinaccruedliabilities": 826556,
    "netcashprovidedbyusedinoperatingactivities": "-null",
    "paymentstoacquireinprocessresearchanddevelopment": 525000,
    "netcashprovidedbyusedininvestingactivities": -525000,
    "proceedsfromconvertibledebt": "null",
    "paymentofdeferredfinancingcostsrelatedtoinitialpublicoffering": 113883,
    "paymentsofdebtissuancecosts": 697828,
    "proceedsfromstockoptionsexercised": 158,
    "netcashprovidedbyusedinfinancingactivities": "null",
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": "null",
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": "null",
    "deferredfinancingcostsinaccountspayableandaccruedexpense": "null",
    "numberofoperatingsegments": 1,
    "deferredfinancecostsgross": 997367,
    "finitelivedintangibleassetscostincurredtoreneworextend": 120992,
    "propertyplantandequipmentusefullife": "five years",
    "shorttermleasecost": 30000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null",
    "cashandcashequivalentsfairvaluedisclosure": "null",
    "convertibledebtfairvaluedisclosures": "null",
    "debtinstrumentcarryingamount": "null",
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityvalue": "null",
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilityissues": "null",
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilityperiodincreasedecrease": "null",
    "prepaidresearchanddevelopment": 175860,
    "prepaidinsurance": "null",
    "otherprepaidexpensecurrent": 24075,
    "propertyplantandequipmentgross": 136804,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 43494,
    "accruedresearchanddevelopment": 135864,
    "accruedemployeebenefitscurrent": 927006,
    "accruedprofessionalfeescurrent": 945491,
    "deferredfinancecostsnet": 997367,
    "placementissuanceofcashfeepercentage": 0.07,
    "warrantsandrightsoutstandingterm": "five years",
    "classofwarrantorrightoutstanding": 92184,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 9.15,
    "licenseagreementoptionfee": 100000,
    "reimbursementofpatentrelatedexpenses": 119420,
    "researchanddevelopmentexpense": "null",
    "preferredstockdividendratepercentage": 0.08,
    "numberofdirector": 1,
    "preferredstockliquidationpreference": 1.338,
    "stockholdersequityreversestocksplit": "one-for-5.6955",
    "commonstockvotingrights": "The holders of common stock are entitled to one vote for each share of common stock held at all meetings of stockholders. Unless required by law, there shall be no cumulative voting.",
    "fairvalueadjustmentofwarrants": 15138,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 790097,
    "commonstockcapitalsharesreservedforfutureissuance": 311089,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 8.7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "four years",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 346417,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 1.9,
    "allocatedsharebasedcompensationexpense": 207346,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 478570,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 151433,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 28158,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 271098,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 478570,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 1.85,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 3.48,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 1.08,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 1.08,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 1.38,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 1.85,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 8.4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": 8.7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 911713,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.033,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 5.6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.8348000000000001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexerciseprice": 3.48,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationpermanentdifferences": 0.046,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.16399999999999998,
    "deferredtaxassetsstartupcosts": "null",
    "deferredtaxassetscapitalizedlicensefees": 47250,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 51795,
    "deferredtaxassetsoperatinglosscarryforwards": 608738,
    "deferredtaxassetstaxdeferredexpenseaccruedexpensesandother": 60521,
    "deferredtaxassetssection174capitalization": 873687,
    "deferredtaxassetsvaluationallowance": "null",
    "deferredtaxassetsnet": 60,
    "deferredtaxliabilitiespropertyplantandequipment": 60,
    "deferredtaxliabilities": 60,
    "operatinglosscarryforwards": "null",
    "taxcreditcarryforwardexcesspercentageofchangeinownershipinterest": 0.5,
    "consultingfees": 30000
  }
]